Redox potential of intercapsomeric disulfides defines pathway of final VLP assembly for HPV

Authors

• Danielle Miller, Merck, USAFollow
• Arthur Dechamps, Bioprocess Drug Substance & Commercialization, Merck & Co., Inc., United States
• Oleksandr Zavalov, Applied Mathematics and Modeling, MMD IT, Merck & Co., Inc., West Point, United States,
• Benjamin Roose, Analytical Research & Development, Merck & Co., Inc., West Point, United States
• Feras Hatahet, Vaccine Process Development, Merck & Co., Inc., West Point, United States, Current address Amgen Inc., United States
• Mark Haverick, Analytical Research & Development, Merck & Co., Inc., West Point, United States
• Emily Wen, Vaccine Process Development, Merck & Co., Inc., West Point, Pennsylvania, United States

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Danielle Miller, Arthur Dechamps, Oleksandr Zavalov, Benjamin Roose, Feras Hatahet, Mark Haverick, and Emily Wen, "Redox potential of intercapsomeric disulfides defines pathway of final VLP assembly for HPV" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/14